SCHEMBL346603

SCHEMBL346603

C[C@](O)(CO)[C@H](O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3797671 1.00
SCHEMBL17867170 1.00
SCHEMBL14602606 1.00
SCHEMBL21594809 1.00
Phosphoric Acid SCHEMBL31556184 0.88 LMNA (0.35)
Phosphoric Acid SCHEMBL27848551 0.88 LMNA (0.35)
SCHEMBL5981774 0.81
SCHEMBL19518719 0.80
SCHEMBL3744808 0.80
SCHEMBL13181400 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 452 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260009063-A1 HIGH-PURITY STEVIOL GLYCOSIDES PURECIRCLE SDN BHD (MY) 2026-01-08 US claimed
US-20250263768-A1 HIGH-PURITY STEVIOL GLYCOSIDES PURECIRCLE USA INC (US) 2025-08-21 US claimed
US-12378590-B2 High-purity steviol glycosides PURECIRCLE USA INC. (US) 2025-08-05 US claimed
EP-4551583-A1 HIGH-PURITY STEVIOL GLYCOSIDES PureCircle SDN BHD (MY) 2025-05-14 EP claimed
CN-119709565-A Production of terpenes method for preparing compounds 西安卓虹超源生物科技有限公司 2025-03-28 CN claimed
WO-2025048633-A2 HIGH-PURITY STEVIOL GLYCOSIDES PURECIRCLE SDN. BHD. (MY) 2025-03-06 WO claimed
US-12227783-B2 Metabolic engineering for microbial production of terpenoid products MANUS BIO INC. (US) 2025-02-18 US claimed
US-20240360489-A1 HIGH-PURITY STEVIOL GLYCOSIDES PURECIRCLE SDN BHD (MY) 2024-10-31 US claimed
EP-4363431-A1 HIGH-PURITY STEVIOL GLYCOSIDES Purecircle SDN BHD (MY) 2024-05-08 EP claimed
CN-117730086-A High purity steviol glycosides 谱赛科有限公司 2024-03-19 CN claimed
US-20120329102-A1 BIOLOGICAL PRODUCTION OF PENTOSE SUGARS USING RECOMBINANT CELLS DANISCO US INC. 2012-12-27 US claimed
WO-2012088450-A1 BIOLOGICAL PRODUCTION OF PENTOSE SUGARS USING RECOMBINANT CELLS DANISCO US INC. (US) 2012-06-28 WO claimed
EP-2084519-A2 ADVANCED DRUG DEVELOPMENT AND MANUFACTURING Los Alamos National Security, LLC (US) 2009-08-05 EP claimed
WO-2008127291-A2 ADVANCED DRUG DEVELOPMENT AND MANUFACTURING LOS ALAMOS NATIONAL SECURITY, LLC (US) 2008-10-23 WO claimed
US-20080220441-A1 Advanced drug development and manufacturing THE REGENTS OF THE UNIVERSITY OF CALIFORNIA 2008-09-11 US claimed
EP-1115849-B1 GENES OF THE 1-DESOXY-D-XYLULOSE BIOSYNTHETIC PATHWAY BIOAGENCY AG (DE) 2006-02-01 EP claimed
EP-1179187-A1 USE OF GENES OF THE DEOXY-D-XYLULOSE PHOSPHATE BIOSYNTHETIC PATHWAY FOR ALTERING THE CONCENTRATION OF ISOPRENOID Jomaa Pharmaka GmbH (DE) 2002-02-13 EP claimed
EP-1115849-A2 GENES OF THE 1-DESOXY-D-XYLULOSE BIOSYNTHETIC PATHWAY Jomaa, Hassan (DE) 2001-07-18 EP claimed
WO-2000072022-A1 USE OF GENES OF THE DEOXY-D-XYLULOSE PHOSPHATE BIOSYNTHETIC PATHWAY FOR ALTERING THE CONCENTRATION OF ISOPRENOID JOMAA PHARMAKA GMBH (DE) 2000-11-30 WO claimed
WO-2000017233-A2 GENES OF THE 1-DESOXY-D-XYLULOSE BIOSYNTHETIC PATHWAY JOMAA PHARMAKA GMBH (DE) 2000-03-30 WO claimed